Genetic database gives hope for potential Parkinson’s treatment

News

Author: Saskia MairPublished: 4 June 2020

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

DNA molecules genetic database

The Genome Aggregation Database (gnomAD) – the world’s largest public database of variations in DNA which can cause diseases – has given scientists hope for a potential Parkinson’s treatment.

UK and US researchers from Imperial College London, the Broad Institute of MIT and Harvard, 23andMe and the Michael J. Fox Foundation used gnomAD to study variants in the LRRK2 gene, which increases the risk of Parkinson’s. Previous studies have shown that blocking the protein formed by the gene can lead to organ damage in animals – but the scientists now suggest this approach should be safe for humans.

Research fellow Dr Nicky Whiffin said: “Large genetic databases are increasingly giving us a powerful insight into the likely impact of certain drugs. If we see that genetic variants that naturally reduce the amount of protein in our body do not result in severe diseases, we can be more confident that targeting that protein therapeutically will also be safe.”


Read more:

Diesel exhaust fumes may increase the risk of Parkinson’s, study suggests

Can Covid-19 increase the risk of developing Parkinson’s?

Go Back

Share this story

Comments


Related articles


A composite image showing a photo of Bob and Liz Taylor next to a photo of Dr Tove Henriksen

Episodes

Podcast: What you need to know about apomorphine pump treatment for Parkinson’s disease

Three guests share their unique perspectives on the treatment

READ MORE
A composite image of Cathy Molohan and Keyoumars Ashkan.

sponsored article

Episodes

Podcast: Deciding to have DBS surgery

Two guests discuss deep brain stimulation for Parkinson’s disease

READ MORE
Parkinson's news

Global update

Parkinson’s in the news: August

A roundup of Parkinson’s news stories in August

READ MORE